What causes of hemolysis should be considered after autoimmune hemolytic anemia, other testable hemolytic disorders, and acute neoplasms have been excluded?

Hereditary Red Cell Enzyme Deficiencies and Membranopathies

After excluding autoimmune hemolytic anemia (AIHA), other testable hemolytic disorders, and acute neoplasms, you should systematically evaluate for hereditary non-immune hemolytic anemias, specifically red cell enzyme deficiencies (particularly pyruvate kinase deficiency), red cell membrane disorders, unstable hemoglobins, and congenital dyserythropoietic anemias 1.

Primary Diagnostic Considerations

The 2019 consensus guidelines on pyruvate kinase deficiency provide a clear diagnostic framework for this scenario 1:

Red Cell Enzyme Deficiencies (Erythroenzymopathies)

Pyruvate kinase (PK) deficiency should be the leading consideration among enzyme deficiencies, as it is the most common red cell enzymopathy after G6PD deficiency 1. Key features include:

• Unremarkable red cell morphology (unlike membrane disorders) - typically only anisocytosis and poikilocytosis
• Reticulocytosis that may be disproportionately low relative to hemolysis severity (due to splenic sequestration of young PK-deficient cells)
• Variable echinocytes (3-30%), especially post-splenectomy
• Iron overload even without transfusions (due to ineffective erythropoiesis)
• Unconjugated bilirubin usually <5 mg/dL

Diagnostic approach for PK deficiency:

1. Measure PK enzymatic activity in red blood cell lysates
2. Confirm with DNA sequence analysis of PKLR gene
3. Study parents/family members when possible to confirm heterozygous state 1

Red Cell Membrane Disorders (Membranopathies)

These differ from enzyme deficiencies by having characteristic morphological abnormalities 1:

• Hereditary spherocytosis - spherocytes on smear
• Hereditary elliptocytosis - elliptocytes
• Hereditary stomatocytosis - important to exclude before splenectomy due to thrombophilic risk

Unstable Hemoglobins

These hemoglobinopathies also show distinctive morphology on peripheral smear, contrasting with the unremarkable appearance in enzyme deficiencies 1.

Congenital Dyserythropoietic Anemias

Consider when dyserythropoietic features are observed on bone marrow examination 1.

Critical Clinical Contexts

Specific scenarios that should trigger consideration of these hereditary causes 1:

• Transfusion-dependent patients without obvious etiology
• Neonates with unexplained severe hyperbilirubinemia
• Increased reticulocytosis after splenectomy in previously undiagnosed hemolytic patients
• Positive family history of hemolytic anemia

Diagnostic Algorithm

The peripheral blood smear is your key decision point 1:

1. If morphology is unremarkable → Suspect enzyme deficiency (especially PK deficiency)

   • Proceed to enzyme activity assays
   • Consider genetic testing panels

2. If characteristic morphology present → Suspect membrane disorder or unstable hemoglobin

   • Spherocytes → hereditary spherocytosis workup
   • Other specific shapes → targeted testing

3. If dyserythropoietic features → Consider congenital dyserythropoietic anemia

   • May require bone marrow examination

Important Pitfalls

• Do not rely on osmotic fragility testing - it can be normal or altered in PK deficiency and is not informative 1
• Reticulocytosis may be misleadingly low in non-splenectomized PK-deficient patients, potentially causing you to overlook hemolysis 1
• Exclude hereditary stomatocytosis before splenectomy - splenectomy is contraindicated due to thrombophilic complications 1
• Check iron studies even without transfusion history - ferritin and transferrin saturation may be disproportionately elevated in PK deficiency 1